A group of clinical researchers released study results revealing that the immunosuppressive drug mycophenolate mofetil (MMF) may be linked to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant (ie. liver transplant) patients.
Read more about the discovery here: http://bit.ly/1VWEhmJ
